Log In
Print this Print this

Wellbutrin, Wellbutrin SR, Wellbutrin XL, bupropion

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionNorepinephrine and dopamine reuptake inhibitor (NDRI)
Molecular Target Not available
Mechanism of ActionDopamine and norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsPrevent major depression associated with seasonal affective disorder (SAD); Treat depression; Treat major depressive disorder (MDD)
Regulatory Designation
Partner GlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today